These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12484062)
1. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP]. Kasugai H; Katayama N; Sakai S; Yamakawa T Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062 [TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989 [TBL] [Abstract][Full Text] [Related]
3. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography. Yukisawa S; Okugawa H; Masuya Y; Okabe S; Fukuda H; Yoshikawa M; Ebara M; Saisho H Eur J Radiol; 2007 Feb; 61(2):279-89. PubMed ID: 17070663 [TBL] [Abstract][Full Text] [Related]
4. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Kwak HS; Lee JM; Kim CS Eur Radiol; 2004 Mar; 14(3):447-57. PubMed ID: 14531005 [TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974 [TBL] [Abstract][Full Text] [Related]
6. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. Ba-Ssalamah A; Heinz-Peer G; Schima W; Schibany N; Schick S; Prokesch RW; Kaider A; Teleky B; Wrba F; Lechner G J Magn Reson Imaging; 2000 Jun; 11(6):665-72. PubMed ID: 10862066 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. Kim YK; Kwak HS; Han YM; Kim CS J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654 [TBL] [Abstract][Full Text] [Related]
10. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions. Macarini L; Marini S; Milillo P; Vinci R; Ettorre GC Radiol Med; 2006 Dec; 111(8):1087-102. PubMed ID: 17171525 [TBL] [Abstract][Full Text] [Related]
11. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging. Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950 [TBL] [Abstract][Full Text] [Related]
12. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Tanimoto A; Kuribayashi S Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230 [TBL] [Abstract][Full Text] [Related]
13. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium]. Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Furuhata T; Okita K; Tsuruma T; Hata F; Kimura Y; Katsuramaki T; Mukaiya M; Hirokawa N; Ichimura T; Yama N; Koito K; Sasaki K; Hirata K Dig Surg; 2003; 20(4):321-5. PubMed ID: 12806198 [TBL] [Abstract][Full Text] [Related]
15. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768 [TBL] [Abstract][Full Text] [Related]
16. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932 [TBL] [Abstract][Full Text] [Related]
17. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver. Müller RD; Vogel K; Neumann K; Hirche H; Barkhausen J; Stöblen F; Henrich H; Langer R Acta Radiol; 1999 Nov; 40(6):628-35. PubMed ID: 10598852 [TBL] [Abstract][Full Text] [Related]
18. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272 [TBL] [Abstract][Full Text] [Related]
19. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging. Kim YK; Kim CS; Kwak HS; Lee JM J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]